Fesarius Therapeutics Competitors and Similar CompaniesClear all

Fesarius Therapeutics's competitors and similar companies include Libbs Farmaceutica, Servier, Aurobindo Pharma and Glenmark Pharmaceuticals.

	Fesarius Therapeutics Fesarius Therapeutics is a company that develops tissue regeneration products.	Libbs Farmaceutica Libbs Farmaceutica is a pharmaceutical company.	Servier Servier, founded in 1954, is the first independent pharmaceutical group.	Aurobindo Pharma Aurobindo Pharma, a pharmaceutical company, manufactures and sells generic medicines to public and private health sectors in South Africa.	Glenmark Pharmaceuticals Glenmark Pharmaceuticals is a pharmaceutical company that develops and markets branded and generic formulations.
Founding Date	Founding Date 2015	Founding Date 1958	Founding Date 1954	Founding Date 1986	Founding Date 1977
Type	Type Private	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech medical devices surgical solutions	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma
Locations	Locations Brooklyn, US HQ	Locations HQ	Locations Suresnes, FR HQ Sidi M'hamed, DZ Yerevan, AM Hawthorn, AU Melbourne, AU Vienna, AT Baku, AZ see more	Locations Hyderabad, IN HQ Hyderabad, IN South Brunswick Township, US	Locations Mumbai, IN HQ Mumbai, IN
Employees	Employees 138% increase	Employees 4,8032% increase	Employees 12,9983% increase	Employees 26,015	Employees 14,989
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₹333.8b (FY, 2026)	Revenue (est.) ₹131.5b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ₹134.9b (FY, 2026)	Cost of goods ₹46.7b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit ₹206.6b (FY, 2026)	Gross profit ₹87b (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income N/A	Net income ₹35b (FY, 2026)	Net income ₹10.5b (FY, 2025)